Daclatasvir Dihydrochloride and Exenatide
Determining the interaction of Daclatasvir Dihydrochloride and Exenatide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclatasvir
Brand name: Daklinza
Synonyms: Daclatasvir
Generic Name: exenatide
Brand name: Byetta Prefilled Pen, Bydureon, Bydureon BCise, Bydureon Pen, Bydureon Tray
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclatasvir Dihydrochloride-Exenatide extended release
- Daclatasvir Dihydrochloride-Exenatide Extended-Release Injection (Bydureon BCise)
- Daclatasvir Dihydrochloride-Exenatide Extended-Release Injection (Bydureon) (Pens)
- Daclatasvir Dihydrochloride-Exenatide Extended-Release Injection (Bydureon) (Trays)
- Daclatasvir Dihydrochloride-Exenatide Injection (Byetta)
- Daclatasvir Dihydrochloride-Exenatide Subcutaneous
- Exenatide-Daclizumab
- Exenatide-Daclizumab Subcutaneous
- Exenatide-Dacogen
- Exenatide-Dacomitinib
- Exenatide-Dactinomycin
- Exenatide-Dactinomycin Injection